Compounds > n-(1-3-benzodioxol-5-ylmethyl)-2-6-dichlorobenzamide

n-(1-3-benzodioxol-5-ylmethyl)-2-6-dichlorobenzamide and Intestinal-Diseases

n-(1-3-benzodioxol-5-ylmethyl)-2-6-dichlorobenzamide has been researched along with Intestinal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for n-(1-3-benzodioxol-5-ylmethyl)-2-6-dichlorobenzamide and Intestinal-Diseases

ArticleYear
Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.
    Clinical science (London, England : 1979), 2017, Jun-01, Volume: 131, Issue:11

    Topics: Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Apoptosis; Benzamides; Benzodioxoles; Chemokines; Cytokines; Drug Evaluation, Preclinical; Enzyme Activation; Inflammation Mediators; Intestinal Diseases; Lung Diseases; Male; Mice, Inbred C57BL; Oxidative Stress; Reperfusion Injury; Toll-Like Receptor 4

2017